Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

1134335

USP

Ciprofloxacin hydrochloride

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

Ciprofloxacin hydrochloride monohydrate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C17H18FN3O3 · HCl · H2O
Número de CAS:
86393-32-0
Peso molecular:
385.82
Número MDL:
MFCD00242856
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
329749408
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

ciprofloxacin

fabricante / nombre comercial

USP

aplicaciones

pharmaceutical (small molecule)

Formato

neat

cadena SMILES

O.Cl.OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O

InChI

1S/C17H18FN3O3.ClH.H2O/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;;/h7-10,19H,1-6H2,(H,23,24);1H;1H2

Clave InChI

ARPUHYJMCVWYCZ-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Nota de análisis

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

PHR1167

Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1174

Fluoroquinolonic acid, Pharmaceutical Secondary Standard; Certified Reference Material

1134324

Análogo de etilendiamino de ciprofloxacino, United States Pharmacopeia (USP) Reference Standard

1278302

Fluoroquinolonic acid, United States Pharmacopeia (USP) Reference Standard

C2190000

Ciprofloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0000198

Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard

Y0000199

Ciprofloxacin hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard

C2190050

Ciprofloxacin impurity A, European Pharmacopoeia (EP) Reference Standard

1134459

Ciprofloxacin formamide, United States Pharmacopeia (USP) Reference Standard

1134346

Ciprofloxacin Related Compound A, United States Pharmacopeia (USP) Reference Standard

1134313

Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard

BP930

Ciprofloxacin impurity standard, British Pharmacopoeia (BP) Reference Standard

BP929

Ciprofloxacin hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR2440

Ciprofloxacin formamide, certified reference material, pharmaceutical secondary standard

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Andrea Meyerhoff et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39(3), 303-308 (2004-08-13)
In August 2000, the US Food and Drug Administration (FDA) approved ciprofloxacin hydrochloride (Cipro; Bayer) for management of postexposure inhalational anthrax. This was the first antimicrobial drug approved by the FDA for use in treating an infection due to a
Lucile Pantel et al.
Antimicrobial agents and chemotherapy (2021-03-10)
NOSO-502 is a preclinical antibiotic candidate of the Odilorhabdin class. This compound exhibits activity against Enterobacteriaceae pathogens, including carbapenemase-producing bacteria and most of the Colistin (CST)-resistant strains. Among a collection of CST-resistant Klebsiella pneumoniae strains harboring mutations on genes pmrAB
Corinne N Thompson et al.
Tropical medicine & international health : TM & IH, 19(10), 1284-1292 (2014-07-30)
The country of Fiji, with a population of approximately 870 000 people, faces a growing burden of several communicable diseases including the bacterial infection typhoid fever. Surveillance data suggest that typhoid has become increasingly common in rural areas of Fiji
Rik Oldenkamp et al.
Chemosphere, 115, 88-94 (2014-02-11)
A methodology was developed for the assessment and comparison of the environmental impact of two alternative pharmaceutical prescriptions. This methodology provides physicians with the opportunity to include environmental considerations in their choice of prescription. A case study with the two
Ziyu Sun et al.
Infection and immunity, 82(4), 1638-1647 (2014-02-05)
Pseudomonas aeruginosa is an opportunistic pathogen that causes acute and chronic infections in humans. Pyocins are bacteriocins produced by P. aeruginosa that are usually released through lysis of the producer strains. Expression of pyocin genes is negatively regulated by PrtR
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico